Coexistence of pemphigus and bullous pemphigoid. 1974

T P Chorzelski, and E Maciejowski, and S Jablonska, and F J DeMento, and R W Grover, and K Holubar, and E H Beutner

UI MeSH Term Description Entries
D007169 Impetigo A common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose. Impetigo Contagiosa,Contagiosa, Impetigo,Contagiosas, Impetigo,Impetigo Contagiosas,Impetigos
D007402 Intertrigo A superficial dermatitis occurring on skin surfaces in contact with each other, such as the axillae, neck creases, intergluteal fold, between the toes, etc. Obesity is a predisposing factor. The condition is caused by moisture and friction and is characterized by erythema, maceration, burning, and exudation.
D008297 Male Males
D010392 Pemphigus Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS. Pemphigus Vulgaris,Pemphigus Foliaceus,Foliaceus, Pemphigus
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

T P Chorzelski, and E Maciejowski, and S Jablonska, and F J DeMento, and R W Grover, and K Holubar, and E H Beutner
May 1989, International journal of dermatology,
T P Chorzelski, and E Maciejowski, and S Jablonska, and F J DeMento, and R W Grover, and K Holubar, and E H Beutner
January 1995, The Journal of dermatology,
T P Chorzelski, and E Maciejowski, and S Jablonska, and F J DeMento, and R W Grover, and K Holubar, and E H Beutner
August 2009, Journal of the European Academy of Dermatology and Venereology : JEADV,
T P Chorzelski, and E Maciejowski, and S Jablonska, and F J DeMento, and R W Grover, and K Holubar, and E H Beutner
April 1979, The British journal of dermatology,
T P Chorzelski, and E Maciejowski, and S Jablonska, and F J DeMento, and R W Grover, and K Holubar, and E H Beutner
January 2013, European journal of dermatology : EJD,
T P Chorzelski, and E Maciejowski, and S Jablonska, and F J DeMento, and R W Grover, and K Holubar, and E H Beutner
August 1999, Lancet (London, England),
T P Chorzelski, and E Maciejowski, and S Jablonska, and F J DeMento, and R W Grover, and K Holubar, and E H Beutner
January 1980, IMJ. Illinois medical journal,
T P Chorzelski, and E Maciejowski, and S Jablonska, and F J DeMento, and R W Grover, and K Holubar, and E H Beutner
June 2006, Auris, nasus, larynx,
T P Chorzelski, and E Maciejowski, and S Jablonska, and F J DeMento, and R W Grover, and K Holubar, and E H Beutner
March 1991, Archives of dermatology,
T P Chorzelski, and E Maciejowski, and S Jablonska, and F J DeMento, and R W Grover, and K Holubar, and E H Beutner
June 2017, BMJ (Clinical research ed.),
Copied contents to your clipboard!